Stryker Corporation SYK

272.36 2.61 0.97% as of 25 Sep
Market cap
$103.9B
P/E
28.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Stryker Corporation (SYK) Revenue growth

Stryker Corporation's revenue growth over the twelve months to 30 June 2026 was 8.48%, down 2.7 percentage points from fiscal 2025 (11.2%). Over the past ten years it has ranged from −3.58% (fiscal 2020) to 19.2% (fiscal 2021); the current reading is higher than 82% of that period. That is in line with the Medical Devices industry median of 8.80% and in line with the Healthcare sector median of 8.26%.

Revenue growth, annual

Annual

Period Revenue growth Change (points)
FY2025 11.2% 0.93
FY2024 10.2% (0.88)
FY2023 11.1% 3.27
FY2022 7.84% (11.37)
FY2021 19.2% 22.79
FY2020 −3.58% (13.01)
FY2019 9.43% 0.13
FY2018 9.30% (0.58)
FY2017 9.88% (3.98)
FY2016 13.9% 11.06

Quarterly

Period Revenue growth Change (points)
Jun 2026 9.42% 6.79
Mar 2026 2.63% (8.79)
Dec 2025 11.4% 1.17
Sep 2025 10.3% (0.82)
42 more quarters

Against its own ten years

Low −3.58% High 19.2%
Ten-year median 9.88%
Current reading's percentile 82

Revenue growth against peers

Company Revenue growth
DXCM DexCom, Inc. compare 15.5%
EW Edwards Lifesciences Corporation compare 14.6%
BSX Boston Scientific Corporation compare 13.5%
MDT Medtronic PLC compare 9.77%
PHG Koninklijke Philips N.V. compare 9.11%
SYK Stryker Corporation 8.48%
STE STERIS plc compare 8.37%
ABT Abbott Laboratories compare 8.06%
GEHC GE HealthCare Technologies Inc. compare 6.51%
Medical Devices industry median 8.80%
Healthcare sector median 8.26%
Market median 7.41%

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on SYK